The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, Rotterdam, 3000 CA, the Netherlands.
Department of Pediatrics, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Environ Health. 2021 May 15;20(1):60. doi: 10.1186/s12940-021-00747-6.
Exposure to bisphenols may affect fetal growth and development. The trimester-specific effects of bisphenols on repeated measures of fetal growth remain unknown. Our objective was to assess the associations of maternal bisphenol urine concentrations with fetal growth measures and birth outcomes and identify potential critical exposure periods.
In a population-based prospective cohort study among 1379 pregnant women, we measured maternal bisphenol A, S and F urine concentrations in the first, second and third trimester. Fetal head circumference, length and weight were measured in the second and third trimester by ultrasound and at birth.
An interquartile range increase in maternal pregnancy-averaged bisphenol S concentrations was associated with larger fetal head circumference (difference 0.18 (95% confidence interval (CI) 0.01 to 0.34) standard deviation scores (SDS), p-value< 0.05) across pregnancy. When focusing on specific critical exposure periods, any detection of first trimester bisphenol S was associated with larger second and third trimester fetal head circumference (difference 0.15 (95% CI 0.05 to 0.26) and 0.12 (95% CI 0.02 to 0.23) SDS, respectively) and fetal weight (difference 0.12 (95% CI 0.02 to 0.22) and 0.16 (95% CI 0.06 to 0.26) SDS, respectively). The other bisphenols were not consistently associated with fetal growth outcomes. Any detection of bisphenol S and bisphenol F in first trimester was also associated with a lower risk of being born small size for gestational age (Odds Ratio 0.56 (95% CI 0.38 to 0.74) and 0.55 (95% CI 0.36 to 0.85), respectively). Bisphenols were not associated with risk of preterm birth.
Higher maternal bisphenol S urine concentrations, especially in the first trimester, seem to be related with larger fetal head circumference, higher weight and a lower risk of being small size for gestational age at birth.
双酚类物质的暴露可能会影响胎儿的生长发育。双酚类物质在各孕期对胎儿生长的重复测量值的具体影响尚不清楚。我们的目的是评估母体尿液中双酚浓度与胎儿生长测量值和出生结局的关系,并确定潜在的关键暴露期。
在一项基于人群的前瞻性队列研究中,我们测量了 1379 名孕妇在第一、二、三期的尿液中的母体双酚 A、S 和 F 浓度。在第二和第三孕期通过超声测量胎儿头围、长度和体重,并在出生时进行测量。
孕期平均双酚 S 浓度的四分位距增加与整个孕期胎儿头围的增大有关(差异 0.18(95%置信区间 0.01 至 0.34)标准差得分(SDS),p 值<0.05)。当关注特定的关键暴露期时,第一孕期任何双酚 S 的检测均与第二和第三孕期胎儿头围的增大有关(差异 0.15(95%置信区间 0.05 至 0.26)和 0.12(95%置信区间 0.02 至 0.23)SDS,分别)和胎儿体重(差异 0.12(95%置信区间 0.02 至 0.22)和 0.16(95%置信区间 0.06 至 0.26)SDS,分别)。其他双酚类物质与胎儿生长结局并不始终相关。第一孕期任何双酚 S 和双酚 F 的检测也与出生时小于胎龄儿的风险降低有关(比值比 0.56(95%置信区间 0.38 至 0.74)和 0.55(95%置信区间 0.36 至 0.85),分别)。双酚类物质与早产风险无关。
较高的母体双酚 S 尿液浓度,尤其是在第一孕期,似乎与胎儿头围较大、体重较高以及出生时小于胎龄儿的风险降低有关。